Christopher Wasden's bio:

Chris Wasden is a managing director in our Health Industries Strategy and Innovation practice. He advises providers, pharmaceutical, medical device, healthcare services, private equity firms, venture capital, and governments on strategic and commercial risks, uncertainties and opportunities associated with their growth and innovation strategies including: mergers and acquisitions, divestitures, corporate venturing, entrepreneurial ventures, and new product and business development. Chris has a rich and diverse background of experience that gives him a unique perspective when assisting clients on their strategic initiatives. He spent nearly a decade on Wall Street as an investment banker doing M&A and corporate finance work around the world for JP Morgan and Union Bank of Switzerland where he executed over $12 billion in transactions. He spent several years in C-level positions with multi-billion dollar private and public companies leading their corporate finance and strategic initiatives. Prior to joining PwC, he spent nearly a decade as a medical technology entrepreneur starting four separate companies, becoming a named inventor on 20 issued and pending patents, evaluating over 100 different medical technologies, raising over $50 million in angel and venture capital commitments, being named by Inc. Magazine as a runner up in their annual Entrepreneur of the Year competition, and taking new ventures to liquidity events. He is a highly sought after public speaker and university lecturer on strategy, entrepreneurship, and innovation, and he has taught undergraduate and graduate courses on these topics at several universities. His proprietary strategy and innovation framework, referred to as Innovation Lifecycle Management, represent the foundation of his practice and enables organizations and leaders to transform maladaptive tension into creative and adaptive ones to accelerate innovation and growth. He successfully leads and advises both small teams and large organizations to achieve strategic growth and innovation objectives through organic, de novo, new venture, and M&A strategies and tactics. Chris holds a doctorate (EdD, abd) in organizational strategy from the George Washington University, as well as an MBA in finance and strategy from the Anderson School at UCLA, and a BA in Asian Studies and a BS in Accounting from Brigham Young University. Chris Wasden has no relevant disclosures.

Christopher Wasden's posts:

The Challenges of Adopting Medical Technology

The medical community typically does not adopt new technologies as rapidly as other industries. Christopher Wasden, MBA, Managing Director, Health [MORE]

Business Model Innovation in Healthcare

Rapid technological advances, regulatory reform, and the new science of personalized medicine are the three primary factors driving [MORE]